Australian takes over helm of global anti-stroke organisation
Posted 10th October, 2012
Congratulations to Melbourne-based Professor Stephen Davis on his appointment as the president of the World Stroke Organisation. Professor Davis is an internationally renowned stroke clinician, researcher and academic, a supporter of the National Stroke Foundation and an industry colleague.
Stephen Davis, MD, FRCP, Edin FRACP, of Melbourne, Australia was named as the new president of the World Stroke Organization (WSO), the Geneva-based international NGO leading the campaign to reduce the global burden of stroke.
Prof. Davis assumed his prestigious position on the eve of the 8th World Stroke Congress being held in the Brazilian capital from 10 to 13 October.
Professor Davis will become the third president of the association since the International Stroke Society and the World Stroke Federation merged in 2004. He will succeed Prof. Bo Norrving, of Sweden, who stepped down after serving the society as its president for the past four years. Prof. Norrving will remain on the WSO Executive Board and will continue his role as the society’s ambassador working closely with public health and policy experts at the United Nations, the World Health Organization (WHO) and with governments worldwide, ensuring that the fight against stroke remains on the global health and development agenda.
Reflecting on his term as leader of the society, Norrving explains “I have had the privilege to serve as president during a period when the WSO has developed in a way I had never imagined when I took office four years ago. In particular, I am very pleased with the increasingly influential role of the WSO as the world voice for stroke within the WHO, other governmental bodies and in the community. Most importantly, the society will be in the best of hands with Steve Davis as my successor – he has all the qualifications needed and more.”
Stephen Davis is the inaugural Professor of Translational Neuroscience at the University of Melbourne. He is based at the Royal Melbourne Hospital (RMH) where he is the Director of Neurosciences and Continuing Care, Director of Neurology and Director of the Melbourne Brain Centre (MBC). His major research interests involve clinical trials in stroke and the use of neuroimaging, particularly multimodal MRI, in the selection of acute stroke treatments. He is the co-principal investigator with Prof. Geoffrey Doonan, a past WSO president, of the EXTEND trial, aimed at extending the time window for thrombolysis using MRI and CTP in treatment selection.
Davis is the immediate past-president of the Australian and New Zealand Association of Neurologists (ANZAN) and a past-president of the Stroke Society of Australasia. An active member of the WSO, he is a long-standing board member of the organization and co-chair of the World Stroke Academy, the society’s educational platform.